<ѻý>Stem Cell Selection Unneeded for SSc Transplant Therapy?ѻý> Small trial suggests a simpler path to defeat systemic sclerosis Dec 03, 2024
<ѻý>HIPEC for Recurrent, Platinum-Sensitive Ovarian Cancer Fails to Improve PFSѻý> More favorable-risk patient population may explain variance from other recent studies Dec 03, 2024
<ѻý>Some Older Adults Think Stopping CRC Screening at Age 75 Is 'Unacceptable'ѻý> Limited life expectancy may not increase acceptance of such guidelines, researchers say Dec 03, 2024
<ѻý>Drug Prices Negotiated by Medicare Still Higher Than Other Countries'ѻý> All drugs except one remained more expensive in the U.S. Dec 02, 2024
<ѻý>HIV Doesn't Cause AIDS and Other Conspiracies RFK Jr. Endorsedѻý> He has also claimed Wi-Fi causes cancer and that antidepressants are to blame for mass shootings Dec 02, 2024
<ѻý>Year in Review: Multiple Myelomaѻý> A drug comeback, new FDA approvals, and a new standard for transplant-ineligible patients Dec 02, 2024
<ѻý>Benefits of HPV Vaccination; Contraindications to Newer Obesity Drugsѻý> Also in TTHealthWatch: minimum effective dose of pneumococcal vaccines Nov 30, 2024 podcast
<ѻý>Lidocaine Fails to Speed Up Gut Function Recovery After Colonic Surgeryѻý> Absence of gut function recovery is the primary reason for extended hospital stays Nov 29, 2024
<ѻý>Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Testsѻý> News, features, and commentary about cancer-related issues Nov 29, 2024
<ѻý>New CAR-T Drug Induces Durable Remissions in ALL, Published Data Showѻý> Results of FELIX study supported obecabtagene autoleucel's recent FDA approval Nov 27, 2024
<ѻý>FDA Investigating Blood Cancer Risk With Gene Therapy Skysonaѻý> Agency is evaluating the need for further regulatory action Nov 27, 2024
<ѻý>TRK Inhibitor Active in Treatment-Refractory Glioblastomaѻý> Also from SNO: Encouraging early results with ATM pathway inhibition, sonodynamic therapy Nov 27, 2024
<ѻý>Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancerѻý> Abemaciclib active in previously treated meningioma, fails to impress in glioblastoma combination Nov 26, 2024
<ѻý>Preoperative Embolization Linked to Relapse-Free Survival in Meningiomaѻý> Significant impact on RFS with subtotal resection, and molecular analysis suggests hypoxic effect Nov 25, 2024
<ѻý>Early Promise for PI3K Inhibitor in Brain Metastasesѻý> Also from SNO: TTFields boosts PFS in glioblastoma, proton therapy for leptomeningeal disease Nov 25, 2024
<ѻý>IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-Upѻý> Two-fold increase in PFS with postoperative ivosidenib holds up in placebo-controlled trial Nov 24, 2024
<ѻý>AMA President-Elect Confronts a New Challenge: A Brain Tumorѻý> Bobby Mukkamala, MD, was diagnosed with grade 2 glioma after experiencing aphasia at AMA meeting Nov 22, 2024
<ѻý>Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapyѻý> Meta-analysis shows better PFS, OS with RT-first approach, but issue requires more study Nov 22, 2024
<ѻý>Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standardsѻý> New treatments reshape metastatic and muscle-invasive bladder cancer therapy Nov 22, 2024 video
<ѻý>Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?ѻý> News, features, and commentary about cancer-related issues Nov 22, 2024
<ѻý>Treatment of Oligometastatic EGFR-Mutant Lung Cancerѻý> More research needed on role of local therapy in new era of treatment Nov 22, 2024
<ѻý>FDA Approves Zanidatamab for Biliary Tract Cancerѻý> New antibody indicated for previously treated, unresectable or metastatic HER2-positive disease Nov 21, 2024
<ѻý>Sacubitril/Valsartan Curbs Cardiotoxicity From Chemotherapyѻý> Benefit shown in trial of patients flagged for high risk of cardiotoxicity Nov 20, 2024
<ѻý>Small Benefit, Persistent Toxic Risk With Adjuvant Anthracycline in Breast Cancerѻý> Time for "long goodbye" to the "burning red devil," say editorialists Nov 19, 2024
<ѻý>Immunotherapy Shows Promise in Downstaging Liver Tumors Prior to Transplantѻý> 78% of patients in prospective study had tumor downstaging with immune checkpoint inhibitors Nov 19, 2024
<ѻý>Does Fluoride Cause Cancer, IQ Loss, and More? Fact-Checking RFK Jr.'s Claimsѻý> Trump's pick to lead HHS has called the mineral "industrial waste" Nov 18, 2024
<ѻý>FDA Approves First Menin Inhibitor for Acute Leukemiaѻý> Complete responses in 21% of patients treated with single-agent revumenib Nov 15, 2024
<ѻý>Response Duration After Stopping Enfortumab Vedotin in Bladder Cancerѻý> Patients with complete response can have long treatment-free interval, study suggests Nov 15, 2024 video
<ѻý>MEK Inhibitor Scores Big Win in Adults, Children With Neurofibromatosis Type 1ѻý> More than 40% of adults, half of children met response criteria, majority of responses durable Nov 15, 2024
<ѻý>Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancerѻý> News, features, and commentary about cancer-related issues Nov 15, 2024
<ѻý>Adding HIPEC Boosts Survival in Recurrent Ovarian Cancerѻý> Results "signal a paradigm shift," expert says Nov 14, 2024
<ѻý>Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Methodѻý> Greatest diagnostic accuracy with experienced dermatologists using dermoscopy Nov 14, 2024
<ѻý>'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrestedѻý> Health news and commentary gathered by ѻý staff Nov 14, 2024
<ѻý>Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survivalѻý> But absence of significant OS benefit raises questions about long-term benefit, expert says Nov 13, 2024
<ѻý>Targeted Combination Shows Promise in Metastatic Kidney Cancerѻý> Other IKCS news: closer look at belzutifan safety, challenges of triplet therapies for RCC Nov 13, 2024
<ѻý>Electronic Symptom Screening in Kids With Cancer Boosts Quality of Careѻý> Improvements seen in pain, neuropathy, and cognitive function Nov 13, 2024
<ѻý>Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortalityѻý> Possible guidance for use of adjuvant immunotherapy in high-risk, non-metastatic disease Nov 12, 2024
<ѻý>AMA Delegates Want Better Protection From Ionizing Radiation Exposureѻý> Delegates express concerns that PPE doesn't always cover women, who are more at risk of exposure Nov 12, 2024
<ѻý>Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapyѻý> Better OS, PFS, response rate, but newer combination strategies not included Nov 12, 2024
<ѻý>Year in Review: Early Breast Cancerѻý> USPSTF screening recommendations, broader indication for ribociclib, OS win for pembrolizumab Nov 12, 2024